<p>Survival curves out to 4.5 years of follow up shown above and Kaplan-Meier estimates of 12-month survival shown below.</p
<p>Scenario A (blue curve) estimated survival based on registry data, which, although collected pros...
<p>Kaplan-Meier survival curves for late presentation and late presentation with advanced disease.</...
<p>Kaplan-Meier survival curve showing the overall survival of the entire patient cohort.</p
<p>After disease onset, the 1-year survival rate was 93.2%, 3-year survival rate was 80.7% and 5-yea...
<p>A. By lymph node involvement, B. By chr3p25, chr11p11 gain. C. By lymph node involvement and chr3...
<p>Kaplan-Meier survival curve for all study participants from randomization to end of extended foll...
<p>The figure shows the comparison between the real survival curve provided by a breast cancer datas...
<p>Kaplan-Meier survival curves by initial modality from day 90, using the entire cohort (Fig 1a, HD...
<p>Kaplan-Meier survival curve of the placebo and the montelukast arm at 2 years.</p
<p>Average follow-up time: 4.8 years. Total follow-up time: 112,820 years. Log rank survival functio...
<p>Kaplan-Meier survival curve for time from HIV diagnosis to viral suppression, by entry to care wi...
<p>Unadjusted Kaplan–Meier curves according to individual conditions (A), cumulative number of condi...
<p>Kaplan-Meier Survival Curves for comparing persistence against interruption and adherence against...
Kaplan-Meier plot showing survival of participants during two years of follow up after completion of...
<p>(A). Overall median survival of 15.0 months; (B) Stratified median survival based on FIGO staging...
<p>Scenario A (blue curve) estimated survival based on registry data, which, although collected pros...
<p>Kaplan-Meier survival curves for late presentation and late presentation with advanced disease.</...
<p>Kaplan-Meier survival curve showing the overall survival of the entire patient cohort.</p
<p>After disease onset, the 1-year survival rate was 93.2%, 3-year survival rate was 80.7% and 5-yea...
<p>A. By lymph node involvement, B. By chr3p25, chr11p11 gain. C. By lymph node involvement and chr3...
<p>Kaplan-Meier survival curve for all study participants from randomization to end of extended foll...
<p>The figure shows the comparison between the real survival curve provided by a breast cancer datas...
<p>Kaplan-Meier survival curves by initial modality from day 90, using the entire cohort (Fig 1a, HD...
<p>Kaplan-Meier survival curve of the placebo and the montelukast arm at 2 years.</p
<p>Average follow-up time: 4.8 years. Total follow-up time: 112,820 years. Log rank survival functio...
<p>Kaplan-Meier survival curve for time from HIV diagnosis to viral suppression, by entry to care wi...
<p>Unadjusted Kaplan–Meier curves according to individual conditions (A), cumulative number of condi...
<p>Kaplan-Meier Survival Curves for comparing persistence against interruption and adherence against...
Kaplan-Meier plot showing survival of participants during two years of follow up after completion of...
<p>(A). Overall median survival of 15.0 months; (B) Stratified median survival based on FIGO staging...
<p>Scenario A (blue curve) estimated survival based on registry data, which, although collected pros...
<p>Kaplan-Meier survival curves for late presentation and late presentation with advanced disease.</...
<p>Kaplan-Meier survival curve showing the overall survival of the entire patient cohort.</p